FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2257120478> ?p ?o ?g. }

• W2257120478 abstract "PURPOSE To investigate whether cytogenetic clonal evolution can be suppressed with interferon alfa (IFN-alpha) therapy in patients with chronic myelogenous leukemia (CML). PATIENTS AND METHODS Ninety patients with CML and cytogenetic clonal evolution who received IFN-alpha-based regimens were analyzed. Clonal evolution was defined as the presence of karyotypic abnormalities in addition to the Philadelphia (Ph) chromosome. Patients were evaluated for the suppression of cytogenetic clonal evolution after therapy, the cytogenetic response, and survival. RESULTS The median age of the population was 39 years (range, 15 to 70 years), median time from diagnosis to clonal evolution 14 months (range, 0 to 145 months), and median percentage of abnormal metaphases 18% (range, 4% to 100%). Fifty six patients (62%) achieved some suppression of cytogenetic clonal evolution; in 41 patients (46%), the suppression was complete. The overall median survival was 51 months, with 43% alive at 5 years. Patients who achieved a complete suppression of cytogenetic clonal evolution had a median survival of 66 months, with 51% alive at 5 years. Characteristics associated with a better response include a lower percentage of abnormal metaphases, time to cytogenetic clonal evolution of 24 months or less, and absence of other features of accelerated disease. A prognostic classification for cytogenetic clonal evolution defined three groups with complete response (CR) rates of 85%, 34%, and 0% (P < .0001) and median survival times of 58, 31, and 30 months, respectively (P=.02). CONCLUSION Patients with cytogenetic clonal evolution can respond to IFN-alpha therapy, and this response is associated with longer survival. A previously described prognostic model separates patients into subsets with different probabilities of response to IFN-alpha and survival." @default.
• W2257120478 created "2016-06-24" @default.
• W2257120478 creator A5011529063 @default.
• W2257120478 creator A5015140142 @default.
• W2257120478 creator A5027575595 @default.
• W2257120478 creator A5038302480 @default.
• W2257120478 creator A5042798628 @default.
• W2257120478 creator A5057701424 @default.
• W2257120478 creator A5084455291 @default.
• W2257120478 creator A5090435894 @default.
• W2257120478 date "1998-10-01" @default.
• W2257120478 modified "2023-09-26" @default.
• W2257120478 title "Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia." @default.
• W2257120478 cites W110083684 @default.
• W2257120478 cites W145164365 @default.
• W2257120478 cites W1830468795 @default.
• W2257120478 cites W1863445368 @default.
• W2257120478 cites W1901923962 @default.
• W2257120478 cites W1965611945 @default.
• W2257120478 cites W1966393359 @default.
• W2257120478 cites W1969718554 @default.
• W2257120478 cites W1979300931 @default.
• W2257120478 cites W1989333836 @default.
• W2257120478 cites W2014894890 @default.
• W2257120478 cites W2028391784 @default.
• W2257120478 cites W2038990138 @default.
• W2257120478 cites W2039978091 @default.
• W2257120478 cites W2071808385 @default.
• W2257120478 cites W2086824226 @default.
• W2257120478 cites W2120079339 @default.
• W2257120478 cites W2255425975 @default.
• W2257120478 cites W2276472705 @default.
• W2257120478 cites W2296922785 @default.
• W2257120478 cites W2337803710 @default.
• W2257120478 cites W2418737431 @default.
• W2257120478 cites W2426940223 @default.
• W2257120478 cites W27058374 @default.
• W2257120478 cites W327786117 @default.
• W2257120478 doi "https://doi.org/10.1200/jco.1998.16.10.3279" @default.
• W2257120478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9779702" @default.
• W2257120478 hasPublicationYear "1998" @default.
• W2257120478 type Work @default.
• W2257120478 sameAs 2257120478 @default.
• W2257120478 citedByCount "28" @default.
• W2257120478 countsByYear W22571204782015 @default.
• W2257120478 countsByYear W22571204782019 @default.
• W2257120478 crossrefType "journal-article" @default.
• W2257120478 hasAuthorship W2257120478A5011529063 @default.
• W2257120478 hasAuthorship W2257120478A5015140142 @default.
• W2257120478 hasAuthorship W2257120478A5027575595 @default.
• W2257120478 hasAuthorship W2257120478A5038302480 @default.
• W2257120478 hasAuthorship W2257120478A5042798628 @default.
• W2257120478 hasAuthorship W2257120478A5057701424 @default.
• W2257120478 hasAuthorship W2257120478A5084455291 @default.
• W2257120478 hasAuthorship W2257120478A5090435894 @default.
• W2257120478 hasConcept C104317684 @default.
• W2257120478 hasConcept C113968399 @default.
• W2257120478 hasConcept C121608353 @default.
• W2257120478 hasConcept C126322002 @default.
• W2257120478 hasConcept C138626823 @default.
• W2257120478 hasConcept C143998085 @default.
• W2257120478 hasConcept C174475383 @default.
• W2257120478 hasConcept C203014093 @default.
• W2257120478 hasConcept C2776178377 @default.
• W2257120478 hasConcept C2776960273 @default.
• W2257120478 hasConcept C2778461978 @default.
• W2257120478 hasConcept C2778904597 @default.
• W2257120478 hasConcept C2781228144 @default.
• W2257120478 hasConcept C2908647359 @default.
• W2257120478 hasConcept C2909179924 @default.
• W2257120478 hasConcept C30481170 @default.
• W2257120478 hasConcept C54355233 @default.
• W2257120478 hasConcept C71924100 @default.
• W2257120478 hasConcept C86803240 @default.
• W2257120478 hasConcept C90924648 @default.
• W2257120478 hasConcept C99454951 @default.
• W2257120478 hasConceptScore W2257120478C104317684 @default.
• W2257120478 hasConceptScore W2257120478C113968399 @default.
• W2257120478 hasConceptScore W2257120478C121608353 @default.
• W2257120478 hasConceptScore W2257120478C126322002 @default.
• W2257120478 hasConceptScore W2257120478C138626823 @default.
• W2257120478 hasConceptScore W2257120478C143998085 @default.
• W2257120478 hasConceptScore W2257120478C174475383 @default.
• W2257120478 hasConceptScore W2257120478C203014093 @default.
• W2257120478 hasConceptScore W2257120478C2776178377 @default.
• W2257120478 hasConceptScore W2257120478C2776960273 @default.
• W2257120478 hasConceptScore W2257120478C2778461978 @default.
• W2257120478 hasConceptScore W2257120478C2778904597 @default.
• W2257120478 hasConceptScore W2257120478C2781228144 @default.
• W2257120478 hasConceptScore W2257120478C2908647359 @default.
• W2257120478 hasConceptScore W2257120478C2909179924 @default.
• W2257120478 hasConceptScore W2257120478C30481170 @default.
• W2257120478 hasConceptScore W2257120478C54355233 @default.
• W2257120478 hasConceptScore W2257120478C71924100 @default.
• W2257120478 hasConceptScore W2257120478C86803240 @default.
• W2257120478 hasConceptScore W2257120478C90924648 @default.
• W2257120478 hasConceptScore W2257120478C99454951 @default.
• W2257120478 hasLocation W22571204781 @default.
• W2257120478 hasLocation W22571204782 @default.
• W2257120478 hasOpenAccess W2257120478 @default.

• next